Cavallo Ventures Hires Brett Morris as Managing Director

Venture capital arm of Wilbur-Ellis focuses on technology, innovation

SAN FRANCISCO – January 11, 2021 – Cavallo Ventures, the venture capital arm of Wilbur-Ellis, announced today the addition of Brett Morris, CFA®, as managing director. Morris will be responsible for evaluating and developing technology investment opportunities for the business divisions of Wilbur-Ellis, a leading international marketer, distributor and manufacturer of agricultural products, animal nutrition and specialty chemicals and ingredients.

Morris’ experience includes leading sourcing, due diligence and execution of investments across the agriculture and animal health and nutrition industries. He also has experience helping incubate and operate an ag biotechnology startup and an animal health product development company, as well as structuring, negotiating and executing commercial licenses, joint ventures, new company spinouts and acquisitions.

“Brett will help us identify early-stage investment opportunities, as well as managing these relationships, evaluating the valuation of investment opportunities and negotiating investment parameters and deal structures. It’s a big job, but with his deep experience in developing opportunities, he’s perfectly suited for Cavallo Ventures,” said Cavallo Ventures’ President and CEO Mike Wilbur.

Brett joins Cavallo Ventures from TechAccel, LLC (also known as Technology Acceleration Partners) in the Kansas City area, where he was vice president and director of investments. Prior to TechAccel, he worked in corporate development and strategy for Lansing Trade Group, a privately owned agribusiness. Throughout his career, Brett has built a strong network of startups, venture capital firms, universities and global corporations. 

To learn more about Cavallo Ventures, visit

About the Wilbur-Ellis Companies
Founded in 1921, the Wilbur-Ellis companies are leading international marketers, distributors and manufacturers of agricultural products, animal nutrients and specialty chemicals and ingredients. By developing strong relationships, making strategic market investments and capitalizing on new opportunities, the Wilbur-Ellis companies have continued to grow the business with sales of over $3 billion. For more information, please visit